Tearsheet

BWX Technologies (BWXT)


Market Price (5/13/2026): $206.58 | Market Cap: $18.9 Bil
Sector: Industrials | Industry: Aerospace & Defense

BWX Technologies (BWXT)


Market Price (5/13/2026): $206.58
Market Cap: $18.9 Bil
Sector: Industrials
Industry: Aerospace & Defense

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 21%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%

Low stock price volatility
Vol 12M is 45%

Megatrend and thematic drivers
Megatrends include Datacenter Power, Hydrogen Economy, and Advanced Aviation & Space. Themes include Mini Nuclear, Show more.

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 42x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 36x, P/EPrice/Earnings or Price/(Net Income) is 55x

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.0%

Key risks
BWXT key risks include [1] a heavy reliance on U.S. Show more.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 21%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%
2 Low stock price volatility
Vol 12M is 45%
3 Megatrend and thematic drivers
Megatrends include Datacenter Power, Hydrogen Economy, and Advanced Aviation & Space. Themes include Mini Nuclear, Show more.
4 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 42x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 36x, P/EPrice/Earnings or Price/(Net Income) is 55x
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.0%
6 Key risks
BWXT key risks include [1] a heavy reliance on U.S. Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

BWX Technologies (BWXT) stock has remained largely at the same level since 1/31/2026 because of the following key factors:

1. Anticipated Strong Financial Performance and "Buy the Rumor, Sell the News" Effect. BWX Technologies consistently surpassed both earnings per share (EPS) and revenue estimates for its Q4 2025 (reported February 23, 2026) and Q1 2026 (reported May 4, 2026) results, and raised its full-year 2026 guidance. For Q4 2025, the company reported an EPS of $1.08 against an estimated $0.89, and revenue of $885.84 million against an $834.84 million forecast. Similarly, Q1 2026 saw non-GAAP EPS of $1.12, beating estimates ranging from $0.92 to $0.94, and revenue of $860.2 million exceeding estimates up to $855.5 million. Despite these strong beats and an upward revision to 2026 guidance for adjusted EBITDA ($650M-$665M), non-GAAP EPS ($4.60-$4.75), and free cash flow ($315M-$330M), the stock's immediate reaction was often muted, or even slightly negative, indicating that much of the positive news was likely already factored into the share price, leading to a "buy the rumor, sell the news" dynamic. For instance, after Q4 2025 results, the stock fell 0.74% in aftermarket trading. Following Q1 2026 results, the stock rose only 0.78% in after-hours trading.

2. Balanced Analyst Sentiment and Price Target Convergence. While BWX Technologies received numerous "Buy" ratings and increased price targets from several analysts throughout the period, this optimism was partially offset by more cautious outlooks. For example, BTIG raised its price target to $235 on February 26, 2026, and B of A Securities increased its target to $250 on March 25, 2026. However, Wells Fargo initiated coverage with an "Underweight" rating and a $200 price target on April 1, 2026. This mixed sentiment, coupled with the stock trading near the median analyst price target of approximately $235.00, suggested that while analysts saw further upside, the stock was already largely reflecting these expectations, thereby limiting significant upward price movements.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 0.8% change in BWXT stock from 1/31/2026 to 5/12/2026 was primarily driven by a 10.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)13120265122026Change
Stock Price ($)205.15206.830.8%
Change Contribution By: 
Total Revenues ($ Mil)3,0593,37610.4%
Net Income Margin (%)10.0%10.2%1.7%
P/E Multiple61.255.0-10.1%
Shares Outstanding (Mil)9292-0.1%
Cumulative Contribution0.8%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/12/2026
ReturnCorrelation
BWXT0.8% 
Market (SPY)3.6%62.6%
Sector (XLI)5.7%69.3%

Fundamental Drivers

The -2.9% change in BWXT stock from 10/31/2025 to 5/12/2026 was primarily driven by a -16.9% change in the company's P/E Multiple.
(LTM values as of)103120255122026Change
Stock Price ($)213.01206.83-2.9%
Change Contribution By: 
Total Revenues ($ Mil)2,8653,37617.9%
Net Income Margin (%)10.3%10.2%-0.7%
P/E Multiple66.255.0-16.9%
Shares Outstanding (Mil)9292-0.1%
Cumulative Contribution-2.9%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/12/2026
ReturnCorrelation
BWXT-2.9% 
Market (SPY)5.5%65.0%
Sector (XLI)13.1%68.0%

Fundamental Drivers

The 90.8% change in BWXT stock from 4/30/2025 to 5/12/2026 was primarily driven by a 56.2% change in the company's P/E Multiple.
(LTM values as of)43020255122026Change
Stock Price ($)108.41206.8390.8%
Change Contribution By: 
Total Revenues ($ Mil)2,7043,37624.9%
Net Income Margin (%)10.4%10.2%-2.1%
P/E Multiple35.255.056.2%
Shares Outstanding (Mil)9292-0.1%
Cumulative Contribution90.8%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/12/2026
ReturnCorrelation
BWXT90.8% 
Market (SPY)30.4%44.3%
Sector (XLI)34.7%53.1%

Fundamental Drivers

The 229.4% change in BWXT stock from 4/30/2023 to 5/12/2026 was primarily driven by a 128.3% change in the company's P/E Multiple.
(LTM values as of)43020235122026Change
Stock Price ($)62.80206.83229.4%
Change Contribution By: 
Total Revenues ($ Mil)2,2333,37651.2%
Net Income Margin (%)10.7%10.2%-4.3%
P/E Multiple24.155.0128.3%
Shares Outstanding (Mil)9192-0.3%
Cumulative Contribution229.4%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2023 to 5/12/2026
ReturnCorrelation
BWXT229.4% 
Market (SPY)78.7%47.7%
Sector (XLI)82.3%54.7%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
BWXT Return-19%23%34%47%56%22%272%
Peers Return-9%-14%69%-8%88%18%167%
S&P 500 Return27%-19%24%23%16%8%97%

Monthly Win Rates [3]
BWXT Win Rate50%50%67%75%67%60% 
Peers Win Rate42%50%58%25%52%52% 
S&P 500 Win Rate75%42%67%75%67%60% 

Max Drawdowns [4]
BWXT Max Drawdown-22%-11%-4%-2%-20%0% 
Peers Max Drawdown-24%-37%-2%-11%-37%-10% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: FLY, ATRO, ARXS, AVEX, ELMT. See BWXT Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/12/2026 (YTD)

How Low Can It Go

EventBWXTS&P 500
2025 US Tariff Shock
  % Loss-16.9%-18.8%
  % Gain to Breakeven20.4%23.1%
  Time to Breakeven20 days79 days
2022 Inflation Shock & Fed Tightening
  % Loss-11.8%-24.5%
  % Gain to Breakeven13.4%32.4%
  Time to Breakeven2 days427 days
2020 COVID-19 Crash
  % Loss-39.6%-33.7%
  % Gain to Breakeven65.5%50.9%
  Time to Breakeven1147 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-41.5%-19.2%
  % Gain to Breakeven70.9%23.7%
  Time to Breakeven354 days105 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-31.2%-17.9%
  % Gain to Breakeven45.3%21.8%
  Time to Breakeven161 days123 days

Compare to FLY, ATRO, ARXS, AVEX, ELMT

In The Past

BWX Technologies's stock fell -16.9% during the 2025 US Tariff Shock. Such a loss loss requires a 20.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventBWXTS&P 500
2020 COVID-19 Crash
  % Loss-39.6%-33.7%
  % Gain to Breakeven65.5%50.9%
  Time to Breakeven1147 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-41.5%-19.2%
  % Gain to Breakeven70.9%23.7%
  Time to Breakeven354 days105 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-31.2%-17.9%
  % Gain to Breakeven45.3%21.8%
  Time to Breakeven161 days123 days

Compare to FLY, ATRO, ARXS, AVEX, ELMT

In The Past

BWX Technologies's stock fell -16.9% during the 2025 US Tariff Shock. Such a loss loss requires a 20.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About BWX Technologies (BWXT)

BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates in three segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group segment provides precision naval and critical nuclear components, reactors, nuclear fuel, and assemblies for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program and other uses; missile launch tubes for United States Navy submarines; close-tolerance and equipment for nuclear applications; and converts Cold War-era government stockpiles of high-enriched uranium, as well as receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; supplies research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. The Nuclear Power Group segment offers commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and containers; engineering and in-plant services for nuclear power plants; designs, manufactures, commissions, and services nuclear power generation equipment; in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and supplies medical radioisotopes and radiopharmaceuticals for research, diagnostic, and therapeutic uses. The Nuclear Services Group segment provides nuclear materials processing, environmental site restoration, and management and operating services; develops technology for nuclear power sources application; and designs, engineers, licenses, and manufactures nuclear reactors. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.

AI Analysis | Feedback

Analogy 1: Think of them as a highly specialized Lockheed Martin or Northrop Grumman, but exclusively focused on building critical nuclear propulsion systems and components for the U.S. Navy's submarines and aircraft carriers.

Analogy 2: They're also like General Electric (GE Vernova) or Siemens Energy, but entirely dedicated to designing, manufacturing, and servicing nuclear power plant components, fuel, and related advanced nuclear technologies.

AI Analysis | Feedback

  • Naval Nuclear Components: Manufactures precision components, reactors, nuclear fuel, and missile launch tubes for the U.S. Naval Nuclear Propulsion Program and defense applications.
  • Commercial Nuclear Power Equipment: Provides nuclear steam generators, fuel, fuel handling systems, pressure vessels, and other components for commercial nuclear power plants.
  • Nuclear Plant Services: Offers engineering, in-plant inspection, maintenance, and modification services for nuclear power plants.
  • Nuclear Fuel & Materials Management: Converts, stores, purifies uranium, and supplies research reactor fuel elements.
  • Medical Radioisotopes: Supplies radioisotopes and radiopharmaceuticals for medical research, diagnostics, and therapeutic uses.
  • Environmental & Nuclear Site Services: Delivers services for nuclear materials processing, environmental site restoration, and site management.
  • Nuclear Reactor Design & Manufacturing: Designs, engineers, licenses, and manufactures nuclear reactors.

AI Analysis | Feedback

BWX Technologies (BWXT) sells primarily to government entities and other companies, rather than individuals. Its major customers include:
  • United States Department of Energy (DOE) / National Nuclear Security Administration (NNSA): These government agencies are major customers for naval nuclear propulsion components, reactors, nuclear fuel, and various nuclear materials processing and management services.
  • United States Navy: A significant government customer for missile launch tubes for submarines and other components for defense applications.
  • Commercial Nuclear Power Plant Operators (Utility Companies): These companies purchase nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, and a range of engineering and in-plant services for nuclear power plants.
  • Research and Academic Institutions: Including colleges, universities, and national laboratories, which acquire research reactor fuel elements and components for various nuclear applications.
  • Medical and Pharmaceutical Companies: For the supply of medical radioisotopes and radiopharmaceuticals used in research, diagnostics, and therapeutics.

AI Analysis | Feedback

null

AI Analysis | Feedback

Rex D. Geveden - President and Chief Executive Officer

Rex D. Geveden has served as President and Chief Executive Officer of BWX Technologies since January 2017, having previously been the Chief Operating Officer from October 2015 to December 2016. Before joining BWXT, Mr. Geveden spent eight years as an executive vice president at Teledyne Technologies, where he led the Digital Imaging and Engineered Systems segments. He also dedicated 17 years to NASA, including a role as the agency's Chief Operating Officer, responsible for a $16 billion portfolio of work across NASA's mission areas. Mr. Geveden chairs the board of TTM Technologies, Inc., a global electronics manufacturing company, and holds bachelor's and master's degrees in physics from Murray State University.

Mike T. Fitzgerald - Senior Vice President and Chief Financial Officer

Mike T. Fitzgerald is the Senior Vice President and Chief Financial Officer for BWX Technologies. He was appointed interim CFO on May 12, 2025, and then permanently to the role on August 1, 2025. Mr. Fitzgerald joined BWXT in 2022 as Vice President of Finance and Chief Accounting Officer. Prior to his tenure at BWXT, he served as the managing director of MorganFranklin, LLC's aerospace and defense practice. His previous experience also includes an audit senior manager role at Deloitte & Touche. He is a Certified Public Accountant, holds a master's degree in business administration from Fitchburg State University, and serves on the board of the nonprofit organization CRi.

Bob Duffy - Senior Vice President and Chief Administrative Officer

Bob Duffy is the Senior Vice President and Chief Administrative Officer for BWXT. In this role, he oversees environmental health and safety operations, other essential administrative functions, and acts as an executive advisor for CEO initiatives. Mr. Duffy has over 30 years of human resources experience and previously served as senior vice president and chief human resources and administration officer for Harris Corporation (now L3Harris Technologies) before joining BWXT.

AI Analysis | Feedback

Key Risks to BWX Technologies (BWXT)

1. Dependence on U.S. Government Contracts and Funding

A predominant portion of BWX Technologies' revenue is derived from contracts with the U.S. government, particularly through the Naval Nuclear Propulsion Program and other Department of Energy/National Nuclear Security Administration initiatives. For instance, approximately 80% of BWXT's revenue is from U.S. government contracts. This heavy reliance exposes the company to significant risks associated with federal budget uncertainty, potential budget cuts, shifts in defense spending priorities, or prolonged government shutdowns. Any changes in government policy or funding levels could directly impact contract visibility, order volumes, and financial performance.

2. Regulatory and Political Risks within the Nuclear Industry

Operating within the highly specialized and sensitive nuclear sector, BWX Technologies is subject to stringent regulations and significant political oversight, impacting both its defense and commercial operations. The nuclear industry faces unique challenges, including evolving safety standards, environmental regulations, and public perception, all of which require continuous investment and can affect the company's cost structure. Any adverse shifts in the political landscape, increased regulatory burdens, or changes in public acceptance of nuclear power could alter the long-term outlook for the company's commercial nuclear power group and associated services. The company is regularly inspected by numerous federal, provincial, and local government regulatory agencies.

AI Analysis | Feedback

null

AI Analysis | Feedback

BWX Technologies, Inc. (BWXT) participates in several key markets related to nuclear technology, including nuclear power plant equipment and services, nuclear fuel, medical radioisotopes and radiopharmaceuticals, and nuclear waste management and decommissioning services. The addressable market sizes for their main products and services are as follows:

  • Nuclear Power Plant Equipment: The global nuclear power plant equipment market was valued at approximately USD 41.7 billion in 2024 and is projected to reach USD 54.6 billion by 2033. Another estimate placed the market size at USD 22.25 billion in 2025, with a projection to reach USD 28.82 billion by 2033. A different report indicated a value of USD 41.1 billion in 2020, expected to reach USD 58.4 billion by 2030. The market for nuclear power plant equipment was also reported as USD 31.72 billion in 2020, growing to USD 38.82 billion by 2030.
  • Nuclear Steam Generators: The global nuclear steam generator market was valued at approximately USD 6.3 billion. Other sources estimate the market size at USD 5.4 billion in 2025, expected to reach USD 7.7 billion by 2032. Another report estimated the market at USD 1132.96 million in 2024, projected to reach USD 1490.89 million by 2031.
  • Nuclear Fuel: The global nuclear fuel market was valued at approximately USD 34.5 billion in 2025 and is forecasted to reach USD 43.9 billion by 2032. Another estimate indicated a market value of USD 34.23 billion in 2025, growing to USD 35.33 billion in 2026. The market was also reported as USD 34.33 billion in 2024, with a projection to reach USD 42.69 billion by 2035. Another source provided a market value of USD 12.13 billion in 2023, expected to reach USD 20.21 billion in 2030.
  • Medical Radioisotopes: The global medical radioisotopes market size was estimated at USD 825.61 million in 2025 and is projected to reach USD 1397.5 million by 2033. Another report valued the market at USD 771.91 million in 2025, expected to reach USD 1558.84 million by 2034. The global medical radioisotopes market was valued at USD 803 million in 2025 and is expected to reach USD 1382 million by 2034.
  • Radiopharmaceuticals: The global radiopharmaceuticals market was valued at USD 16.30 billion in 2024 and is expected to reach USD 26.98 billion by 2032. Another source reported the market size as USD 7.9 billion in 2023, estimated to reach USD 21.8 billion by 2033. Other estimates include a market size of USD 6.74 billion in 2024, predicted to increase to USD 14.44 billion by 2034. The market was also valued at USD 6.80 billion in 2024, projected to grow to USD 16.87 billion by 2033. Additionally, the global radiopharmaceuticals market size was reported as USD 8125.2 million in 2024, expected to reach USD 16657.59821 million by 2031.
  • Nuclear Waste Management: The global nuclear waste management market size was valued at USD 8.25 billion in 2024 and is projected to grow to USD 11.44 billion by 2032. Other figures include a market value of USD 20.39 billion in 2022. Another report provided a market size of USD 4.87 billion in 2024, projected to reach USD 5.87 billion by 2034. The market was also valued at USD 6.06 billion in 2025, growing to USD 7.69 billion by 2031. The global nuclear waste management market was valued at USD 4.78 billion in 2022.
  • Nuclear Decommissioning Services: The global nuclear decommissioning services market was valued at approximately USD 7.54 billion in 2024 and is predicted to grow to around USD 13.12 billion by 2034. Other estimates include a market size of USD 7.5 billion in 2025, expected to reach USD 11.2 billion by 2034. The market was valued at USD 7.37 billion in 2025 and is expected to reach USD 12.99 billion by 2033. Another report estimated the market size at USD 8,170.1 million in 2023. Additionally, the global market size for nuclear decommissioning services was estimated at USD 7.04 billion in 2024 and is predicted to reach USD 11.49 billion in 2033.

For highly specialized products and services such as precision naval and critical nuclear components, reactors, nuclear fuel, and assemblies for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program, missile launch tubes for United States Navy submarines, and close-tolerance equipment for nuclear applications, specific addressable market sizes are null due to their niche government procurement nature rather than open commercial markets.

AI Analysis | Feedback

BWX Technologies (BWXT) is expected to drive future revenue growth over the next 2-3 years through several key areas:
  • Robust Demand in Government Nuclear Programs: BWXT anticipates continued strong demand within its Government Operations segment, particularly from the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program. This includes new pricing agreements for naval propulsion equipment and fuel, along with initial contracts for U.S. defense uranium enrichment and expanded high-purity depleted uranium (HPDU) production. The government operations segment is projected to achieve low to mid-teens growth, with a significant portion stemming from defense fuels and HPDU contracts.
  • Expansion in Commercial Nuclear Power: The company is poised for substantial growth in its Commercial Operations segment, driven by projects such as CANDU refurbishments in Canada and other international markets, design awards for Small Modular Reactor (SMR) components, and the significant $1.6 billion Bulgaria AP1000 contract. Commercial operations reported impressive organic revenue growth and are expected to see approximately 25% growth in 2026.
  • Growth in Medical Isotopes and Radiopharmaceuticals: BWXT Medical is a key growth area, with anticipated double-digit revenue growth stemming from PET and other diagnostic product lines. Furthermore, increasing therapeutic isotope sales for clinical trials and the progressing development of TEK-ninety nine are expected to support continued revenue growth in this sector.
  • Strategic Acquisitions and Record Backlog: Strategic acquisitions, such as AOT in government operations and Kinectrics in commercial operations during 2025, have expanded BWXT's service and product portfolio and contributed to revenue and backlog growth. The company ended 2025 with a record backlog of $7.3 billion, a 50% increase year-over-year, which provides strong visibility and predictability for future revenue generation from multi-year awards in naval propulsion, special materials, and commercial nuclear power.

AI Analysis | Feedback

Share Repurchases

  • A new $500 million share repurchase authorization with no expiration date was approved on April 30, 2021.
  • BWX Technologies completed $20.0 million in share repurchases during the first quarter of 2021.
  • The company spent approximately $30 million on share buybacks in 2025.

Share Issuance

  • BWX Technologies completed a $1.25 billion convertible debt offering with a 0% coupon in the fourth quarter of 2025 (reported in February 2026).
  • The net proceeds from this offering, estimated at approximately $1,075.3 million, were intended for funding capped call transactions, repaying existing credit facility indebtedness, and for general corporate purposes.
  • The convertible notes will mature on November 1, 2030, with an initial conversion rate of 3.8094 shares of common stock per $1,000 principal amount, equating to an initial conversion price of approximately $262.51 per share.

Outbound Investments

  • BWX Technologies completed the acquisition of Kinectrics Inc. in May 2025 for $525 million, expanding its nuclear power plant lifecycle support and radiopharmaceutical isotope production capabilities.
  • The company also completed the acquisition of AOT in 2025.
  • These acquisitions were strategic, aimed at expanding BWXT's service and product offerings, particularly within its commercial nuclear operations.

Capital Expenditures

  • Capital expenditures in 2025 totaled $185 million, representing 5.8% of sales.
  • Expected capital expenditures for 2026 are projected to be about 6% of sales.
  • These expenditures are primarily focused on ongoing growth investments, supporting commitments to government customers, meeting increasing demand in commercial markets, and building out facilities and infrastructure, including the expansion of the Cambridge manufacturing plant for the commercial nuclear market.

Better Bets vs. BWX Technologies (BWXT)

Trade Ideas

Select ideas related to BWXT.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
GEO_4302026_Dip_Buyer_ValueBuy04302026GEOGEODip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
0.0%0.0%0.0%
RUN_4302026_Short_Squeeze04302026RUNSunrunSpecialShort Squeeze PotentialShort Squeeze Potential
Has potential for a short squeeze. High short interest, rising short interest and high debt.
0.0%0.0%0.0%
RSG_4172026_Monopoly_xInd_xCD_Getting_Cheaper04172026RSGRepublic ServicesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
0.8%0.8%-1.1%
VRSK_4102026_Dip_Buyer_FCFYield04102026VRSKVerisk AnalyticsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
12.3%12.3%0.0%
UHAL_4102026_Monopoly_xInd_xCD_Getting_Cheaper04102026UHALU-HaulMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
0.3%0.3%-1.0%
BWXT_8312025_Quality_Momentum_RoomToRun_10%08312025BWXTBWX TechnologiesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
27.3%33.9%-1.2%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

BWXTFLYATROARXSAVEXELMTMedian
NameBWX Tech.Firefly .AstronicsArxis AEVEX Elmet  
Mkt Price206.8339.3278.2636.2628.1516.7437.79
Mkt Cap19.06.32.8---6.3
Rev LTM3,376185862---862
Op Inc LTM334-29876---76
FCF LTM328-25743---43
FCF 3Y Avg285-11---148
CFO LTM522-21175---75
CFO 3Y Avg453-27---240

Growth & Margins

BWXTFLYATROARXSAVEXELMTMedian
NameBWX Tech.Firefly .AstronicsArxis AEVEX Elmet  
Rev Chg LTM21.4%70.7%8.4%---21.4%
Rev Chg 3Y Avg14.3%-17.5%---15.9%
Rev Chg Q26.1%44.8%15.1%---26.1%
QoQ Delta Rev Chg LTM5.6%15.7%3.8%---5.6%
Op Inc Chg LTM2.9%-37.2%188.7%---2.9%
Op Inc Chg 3Y Avg1.6%-254.4%---128.0%
Op Mgn LTM9.9%-161.1%8.9%---8.9%
Op Mgn 3Y Avg11.7%-3.7%---7.7%
QoQ Delta Op Mgn LTM-0.2%2.0%2.9%---2.0%
CFO/Rev LTM15.5%-114.1%8.7%---8.7%
CFO/Rev 3Y Avg15.7%-3.0%---9.3%
FCF/Rev LTM9.7%-139.3%5.0%---5.0%
FCF/Rev 3Y Avg9.9%-1.1%---5.5%

Valuation

BWXTFLYATROARXSAVEXELMTMedian
NameBWX Tech.Firefly .AstronicsArxis AEVEX Elmet  
Mkt Cap19.06.32.8---6.3
P/S5.634.03.2---5.6
P/Op Inc56.7-21.136.5---36.5
P/EBIT41.7-17.836.4---36.4
P/E55.0-18.795.0---55.0
P/CFO36.3-29.837.3---36.3
Total Yield2.3%-5.3%1.1%---1.1%
Dividend Yield0.5%0.0%0.0%---0.0%
FCF Yield 3Y Avg2.5%-0.3%---1.4%
D/E0.10.00.1---0.1
Net D/E0.1-0.10.1---0.1

Returns

BWXTFLYATROARXSAVEXELMTMedian
NameBWX Tech.Firefly .AstronicsArxis AEVEX Elmet  
1M Rtn-9.9%4.7%8.0%-6.4%4.5%-6.5%-0.9%
3M Rtn3.6%71.0%4.9%-6.4%4.5%-6.5%4.1%
6M Rtn6.0%105.5%63.2%-6.4%4.5%-6.5%5.3%
12M Rtn94.4%-34.8%168.1%-6.4%4.5%-6.5%-0.9%
3Y Rtn219.5%-34.8%402.3%-6.4%4.5%-6.5%-0.9%
1M Excs Rtn-18.6%-6.1%-2.2%-13.9%-2.9%-14.0%-10.0%
3M Excs Rtn-3.0%64.3%-1.7%-13.0%-2.1%-13.1%-2.5%
6M Excs Rtn-2.8%89.2%56.6%-16.4%-5.5%-16.5%-4.1%
12M Excs Rtn61.3%-65.6%153.6%-37.2%-26.2%-37.3%-31.7%
3Y Excs Rtn147.1%-113.8%337.0%-85.4%-74.4%-85.5%-79.9%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Government Operations2,1832,0311,808  
Commercial Operations524466427  
Eliminations-3-1-3 -31
Nuclear Operations Group    1,646
Nuclear Power Group    371
Nuclear Services Group    136
Total2,7042,4962,233 2,124


Operating Income by Segment
$ Mil20252024202320222021
Government Operations378375337  
Commercial Operations473827  
Unallocated Corporate-44-29-15 -24
Nuclear Operations Group    326
Nuclear Power Group    52
Nuclear Services Group    26
Other    -22
Total381383349 359


Price Behavior

Price Behavior
Market Price$206.83 
Market Cap ($ Bil)18.9 
First Trading Date08/02/2010 
Distance from 52W High-13.2% 
   50 Days200 Days
DMA Price$212.79$192.40
DMA Trendupup
Distance from DMA-2.8%7.5%
 3M1YR
Volatility51.8%45.6%
Downside Capture1.370.85
Upside Capture245.10207.31
Correlation (SPY)59.9%43.3%
BWXT Betas & Captures as of 4/30/2026

 1M2M3M6M1Y3Y
Beta2.822.332.252.331.591.13
Up Beta3.102.432.401.991.151.08
Down Beta5.090.950.722.111.731.21
Up Capture156%288%302%344%313%210%
Bmk +ve Days15223166141428
Stock +ve Days12223263143407
Down Capture439%245%230%201%136%100%
Bmk -ve Days4183056108321
Stock -ve Days10213262109345

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BWXT
BWXT92.6%45.5%1.57-
Sector ETF (XLI)30.0%15.6%1.4853.1%
Equity (SPY)28.3%12.5%1.8044.0%
Gold (GLD)41.3%26.9%1.2626.9%
Commodities (DBC)47.5%18.0%2.10-3.8%
Real Estate (VNQ)12.8%13.5%0.6519.4%
Bitcoin (BTCUSD)-21.0%41.7%-0.4627.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BWXT
BWXT27.3%32.7%0.79-
Sector ETF (XLI)12.7%17.4%0.5753.9%
Equity (SPY)12.9%17.1%0.5945.8%
Gold (GLD)21.0%17.9%0.9520.3%
Commodities (DBC)13.4%19.1%0.5713.2%
Real Estate (VNQ)3.9%18.8%0.1132.5%
Bitcoin (BTCUSD)7.2%55.9%0.3420.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BWXT
BWXT21.3%30.7%0.69-
Sector ETF (XLI)14.0%20.0%0.6252.8%
Equity (SPY)15.1%18.0%0.7246.7%
Gold (GLD)13.4%15.9%0.7013.0%
Commodities (DBC)9.7%17.7%0.4620.8%
Real Estate (VNQ)5.6%20.7%0.2434.2%
Bitcoin (BTCUSD)68.2%66.8%1.0710.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4302026
Short Interest: Shares Quantity2.9 Mil
Short Interest: % Change Since 4152026-9.2%
Average Daily Volume1.0 Mil
Days-to-Cover Short Interest2.8 days
Basic Shares Quantity91.7 Mil
Short % of Basic Shares3.2%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/4/2026-4.9%-2.7% 
2/23/20262.9%9.1%3.4%
11/3/2025-7.2%-7.9%-17.3%
8/4/202517.8%15.1%4.3%
5/5/2025-3.5%-4.4%15.3%
2/24/20254.2%1.6%5.1%
11/4/2024-2.3%5.7%9.2%
8/5/20240.9%5.3%7.1%
...
SUMMARY STATS   
# Positive131718
# Negative1175
Median Positive4.2%5.3%6.6%
Median Negative-2.3%-4.4%-5.7%
Max Positive17.8%26.3%28.5%
Max Negative-7.6%-7.9%-18.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/04/202610-Q
12/31/202502/23/202610-K
09/30/202511/03/202510-Q
06/30/202508/04/202510-Q
03/31/202505/05/202510-Q
12/31/202402/24/202510-K
09/30/202411/04/202410-Q
06/30/202408/05/202410-Q
03/31/202405/06/202410-Q
12/31/202302/27/202410-K
09/30/202311/01/202310-Q
06/30/202308/03/202310-Q
03/31/202305/08/202310-Q
12/31/202202/23/202310-K
09/30/202211/07/202210-Q
06/30/202208/08/202210-Q

Recent Forward Guidance [BETA]

Latest: Q1 2026 Earnings Reported 5/4/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue 3.75 Bil 0 AffirmedGuidance: 3.75 Bil for 2026
2026 Adjusted EBITDA650.00 Mil657.50 Mil665.00 Mil0.8% RaisedGuidance: 652.50 Mil for 2026
2026 Non-GAAP Earnings Per Share4.64.674.751.1% RaisedGuidance: 4.62 for 2026
2026 Free Cash Flow315.00 Mil322.50 Mil330.00 Mil3.2% RaisedGuidance: 312.50 Mil for 2026

Prior: Q4 2025 Earnings Reported 2/23/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue 3.75 Bil 21.0% Higher NewActual: 3.10 Bil for 2025
2026 Adjusted EBITDA645.00 Mil652.50 Mil660.00 Mil14.5% Higher NewActual: 570.00 Mil for 2025
2026 Non-GAAP Earnings Per Share4.554.624.722.5% Higher NewActual: 3.77 for 2025
2026 Free Cash Flow305.00 Mil312.50 Mil320.00 Mil9.6% Higher NewActual: 285.00 Mil for 2025

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Geveden, Rex DPresident and CEODirectSell5122026204.8110,0002,048,12441,472,673Form
2Fitzgerald, Michael ThomasSVP & Chief Financial OfficerDirectSell5122026209.252,417505,7571,440,477Form
3Gorman, Kevin JamesVP & Chief Accounting OfficerDirectSell3042026214.711,344288,57424,477Form
4Burbach, Gerhard F DirectSell2272026208.611,983  Form
5Geveden, Rex DPresident and CEODirectSell2132026203.2610,0002,032,56036,097,044Form